BACKGROUND Advancements in the quality and availability of highly sensitive analytical
instrumentation and methodologies have led to increased interest in the use of microsamples. …

Novel approaches to improving disaster response have begun to include the use of big data
and information and communication technology (ICT). However, there remains a dearth of …

Background Monoclonal antibodies (mAbs) against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are a promising treatment for limiting the progression of …

Indexed literature (from 2015 to 2020) on artificial intelligence (AI) technologies and machine
learning algorithms (ML) pertaining to disasters and public health emergencies were …

Objective: Disasters of all varieties have been steadily increasing in frequency. Simultaneously,
“big data” has seen explosive growth as a tool in business and private industries while …

The COVID-19 pandemic wrought significant health, political, and economic disruption
globally. From the onset of the pandemic, governments, multinational agencies, and the public …

Monoclonal antibody therapeutics to treat coronavirus disease (COVID-19) have been
authorized by the US Food and Drug Administration under Emergency Use Authorization (EUA). …

Background The COVID-19 pandemic has significantly stressed healthcare systems. The
addition of monoclonal antibody (mAb) infusions, which prevent severe disease and reduce …

Background: Monoclonal antibodies (mAbs) against SARS-CoV-2 are a promising treatment
for limiting the progression of COVID-19 and decreasing strain on hospitals. Their use, …

ObjectiveWe aimed to quantitatively gauge local public health workers’ perceptions toward
disaster recovery role expectations among jurisdictions in New Jersey and Maryland affected …